Drug Topics
OCTOBER 16, 2024
Posters presented at ACCP 2024 revealed gaps in pharmacy students’ understanding of off-label drug applications and identified strengths and weaknesses among pharmacy graduates.
STAT
OCTOBER 16, 2024
If you’re aware of the H5N1 bird flu outbreak in U.S. dairy cattle — you may have seen some headlines or read something on social media — perhaps you are wondering what the fuss is about. Yes, there have been nearly a couple dozen human cases, but all have had mild symptoms. The virus does not decimate herds in the way it does poultry flocks; most — though not all — of the infected cows come through the illness OK.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
OCTOBER 16, 2024
In an installment of Drug Topics’ 5 Questions With a Pharmacist, Stevie Veach of MercyOne Pharmacy in Dubuque, Iowa, talked about her pharmacy’s offerings and how they serve her community’s patients.
STAT
OCTOBER 16, 2024
The emails from UnitedHealth Group managers were filled with exclamation marks and pleasantries about the weather. But the underlying message to doctors in late 2020 was persistent and urgent: Hit your targets to see more patients. We need to bring in more money. At the time, deaths from Covid-19 were surging, and no vaccine was available.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Topics
OCTOBER 16, 2024
David Pope, PharmD, Chief Pharmacy Officer at XiFin, further discussed value-based care and his company’s ongoing collaboration with pharmacies across the country.
STAT
OCTOBER 16, 2024
Barney Graham, who for decades helped lead U.S. vaccine development efforts , said Wednesday that the lack of cooperation among U.S. agencies is hindering the country’s response to the H5N1 bird flu outbreak among dairy cattle, echoing criticisms that have been building over the past six months. “The USDA and the CDC and the NIH are not sharing and coordinating,” Graham said, referring to the federal agriculture department, the Centers for Disease Control and Preventio
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
OCTOBER 16, 2024
They call it “failure to rescue,” which means a surgical patient died from complications that might have been averted if recognized and treated. New research suggests that’s why women are less likely to survive high-risk cardiovascular surgery than men. Female patients who underwent four common but serious procedures — abdominal aortic aneurysm repair, coronary artery bypass surgery, or atrial or mitral valve replacements — later developed complications a
Drug Topics
OCTOBER 16, 2024
Pharmacist-led medication therapy management can help reduce costs associated with diabetes management.
STAT
OCTOBER 16, 2024
If it weren’t for Martin Shkreli, better known as the Pharma Bro, Mark Cuban might not have gone into the drug business. That’s what he told me in this week’s episode of the “First Opinion Podcast.” He first started speaking with Alex Oshmyansky — the radiologist who would become his co-founder in Mark Cuban Cost Plus Drugs — around when Shkreli was heading to prison.
Drug Topics
OCTOBER 16, 2024
David Pope, PharmD, Chief Pharmacy Officer at XiFin, discussed pharmacy benefit managers and their impact on value-based care within pharmacies.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
OCTOBER 16, 2024
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning! My editor said that the uncertainty in my write-up below on Helen’s story (“ Is it time to freak out about bird flu? “) reminded her of this iconic moment from NBC’s “30 Rock.
Drug Topics
OCTOBER 16, 2024
Gepotidacin is a first-in-class oral antibiotic with a novel mechanism of action.
STAT
OCTOBER 16, 2024
Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us. After all, we have made it this far, so we are determined to hang on for another couple of days. And why not? The alternatives — at least those we can identify — are not so appetizing. And what better way to make the time fly than to keep busy.
Pharmacy Times
OCTOBER 16, 2024
Advanced cell therapies are now saving the lives of people whose blood cancer would previously have been incurable. While the UK was quick to recognize the potential of these innovative therapies, patient access to these therapies may change without continued investment in the UK's cell therapy infrastructure.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
OCTOBER 16, 2024
This story first appeared in The Readout newsletter. Sign up for The Readout and receive STAT’s award-winning biotech news delivered straight to your inbox. Good morning. I’ve arrived in Boston for our annual STAT summit , and I successfully guilted my colleague Adam Feuerstein into baking me a cheesecake.
Fierce Healthcare
OCTOBER 16, 2024
Microsoft recently unveiled several new artificial intelligence capabilities for healthcare organizations designed to help analyze diverse medical data, streamline nursing documentation and enable | Microsoft recently unveiled several new AI capabilities for healthcare organizations designed to help analyze diverse medical data, streamline nursing documentation and enable companies to build their own healthcare AI agents.
STAT
OCTOBER 16, 2024
Robert Califf, a cardiologist and commissioner of the U.S. Food and Drug Administration, has been deeply involved in cardiovascular research: investigating health outcomes, health care quality, and clinical research in large, complex studies. In a recent conversation with STAT, though, he invoked his role as a grandfather, challenged in a grocery store checkout line to resist the ultra-processed foods marketed to American children and adults.
pharmaphorum
OCTOBER 16, 2024
Pfizer partners with US biotech Triana Biomedicines in a deal focusing on molecular glue degraders that could be worth $1.
Fierce Pharma
OCTOBER 16, 2024
With Gilead sprinting to a likely approval next year for its long-acting pre-exposure | With GSK girding for competition from Gilead Sciences, the company has presented strong results from three real-world studies of its bi-monthly injection for HIV prevention.
Pharmacy Times
OCTOBER 16, 2024
Pharmacogenomic testing can help identify patients' genetic profiles, revealing why certain drugs may be less effective or cause adverse effects.
Fierce Healthcare
OCTOBER 16, 2024
David Tsay, M.D., was appointed chief medical officer of Counterpart Health, a Clover Health subsidiary, this month. | Clover Health subsidiary Counterpart Health hired David Tsay, M.D., as its new chief medical officer. Fierce Healthcare spoke with Tsay to hear his thoughts on what makes Clover unique.
STAT
OCTOBER 16, 2024
Inspiration for a career in science can come from any number of sources. For Diane Shao , a neurogeneticist at Boston Children’s Hospital and general partner at Legacy Venture Capital, her mother motivated her to take the plunge into biotech. For Jorge Diego Martin-Rufino , a physician scientist at the Broad Institute and Boston Children’s Hospital, it was the pioneering geneticist Eric Lander, who advised him during his Ph.D.
Fierce Pharma
OCTOBER 16, 2024
As Sanofi moves forward with talks to potentially sell a 50% stake its consumer health unit Opella, fears of job cuts and drug shortages have prompted a call for industrial action in the company’s | French unions have urged Sanofi employees to strike from the start of their shifts Thursday in a move covering “the whole of France." The industrial action hinges on concerns over job cuts and drug shortages tied to Sanofi's potential consumer health stake sale.
Pharmacy Times
OCTOBER 16, 2024
The drug's safety profile included significant rates of nausea, vomiting, and hematologic toxicities like neutropenia and thrombocytopenia. Although promising, brigimadlin requires careful management of adverse effects, including antiemetic and hematologic support.
Fierce Healthcare
OCTOBER 16, 2024
Gastrointestinal virtual care company Oshi Health announced a $60 million series C round led by Oak HC/FT. | Virtual GI care company Oshi Health secured $60 million in a series C round that was kicked off when an investor approached them. Oak FC/HT led the round.
Fierce Pharma
OCTOBER 16, 2024
A federal judge in Delaware has ruled in favor of Exelixis in its Cabometyx patent fight with MSN Laboratories, effectively pushing the earliest generic entry out to 2030. | A federal judge in Delaware has ruled in favor of Exelixis in its Cabometyx patent fight with MSN Laboratories, effectively pushing the earliest generic entry out to 2030.
Fierce Healthcare
OCTOBER 16, 2024
Medicare's annual enrollment period is officially underway, and, to assist beneficiaries in selecting plans, U.S. | Medicare's annual enrollment period is officially underway, and to assist beneficiaries in selecting plans, U.S. News & World Report has released its list of the best Medicare Advantage and Part D insurers.
pharmaphorum
OCTOBER 16, 2024
The pandemic served as a catalyst for a revolution in genomic surveillance for tracking pathogens. The technology proved vital in aiding understanding of the evolution of and spread of virus in real time to inform public health measures, ultimately accelerating drug and vaccine development.
Pharmacy Times
OCTOBER 16, 2024
Gepotidacin could be first-in-class oral antibiotic treatment approved for uUTIs in over 20 years.
pharmaphorum
OCTOBER 16, 2024
Shares in Wave Life Sciences rose by 74% after it reported clinical data with a pioneering RNA-editing therapy for alpha-1 antitrypsin deficiency (AATD)
The Guardian - Pharmaceutical Industry
OCTOBER 16, 2024
More than 200 doctors and experts warn health secretary of ‘enormous pressure’ on already stretched services More than 200 doctors and medical experts have warned that the unprecedented demand for new obesity drugs is threatening to overwhelm the NHS. In a joint letter to the health secretary, Wes Streeting, the healthcare professionals call for an urgent review of services for millions of people struggling with weight.
STAT
OCTOBER 16, 2024
Onward Medical is betting big on neurostimulation as a tool to improve the quality of life for people with paralysis, said CEO Dave Marver. Bullish after recent clinical success, Marver spoke about the Swiss company’s future plans at the 2024 STAT Summit in Boston, including a device that can better regulate an underactive bladder.
European Pharmaceutical Review
OCTOBER 16, 2024
Three industry partners have agreed to collaborate to develop an intensified perfusion process for manufacturing adeno-associated virus (AAV) vectors, leading to improved gene therapy production. The two-year project is supported by a £1.4 million grant through the Innovate UK Transforming Medicines Manufacturing (TMM) Programme, and involves the Cell and Gene Therapy (CGT) Catapult , Pharmaron Biologics (UK) Ltd and Complement Therapeutics.
PharmD Live
OCTOBER 16, 2024
Every October , American Pharmacist Month offers an opportunity to honor the critical contributions pharmacists make to patient care. As medication experts, pharmacists play a key role in ensuring that patients receive the appropriate medications and understand how to use them safely and effectively. With the increasing complexity of healthcare—driven by the rise in chronic diseases and the demands of value-based care (VBC)—the role of pharmacists has never been more essential.
Expert insights. Personalized for you.
131 
Let's personalize your content